RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 27 - per page Next page
Order by
ORS effervescent tablet (Oral Rehydration Salts)
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Cellophil™ Biomedical Polymers - New and superior biomedical polymers for drug delivery and new standards in the medical device industry
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Collatamp® G US
Surgical implant for treatment and prevention of post-operative infections More
Vascular Clip and Devices for Sutureless Anastomosis and Bypasses (08-31_09-09)
Novel Surgical Clips for Vascular Bypass and Tissue Grafts for Vascular surgery, vascular grafts, sutureless anastomosis and bypass surgery More
Multilayered controlled release oral solid pharmaceutical forms
Multilayered controlled release oral solid pharmaceutical composition in tablet form suitable for oral administration comprising at least two layers containing active material in association with excipients and additives. More
Cripto-1 as a Biomarker for Cardiac Ischemia
Cripto-1 is overexpressed in infarcted myocardial tissue More
BiliSuit – a Fiber optic LED form fitting garment for treatment of infant hyperbilirubinemia (09-03)
Portable phototherapy device to treat jaundiced infants More
Use of Attenuated Viruses for Delivery of Cytokines (TID - 13)
This viral vector could be used effectively in hospitals around the world to aid in heart transplants or heart diseases. More
Manufacture Microbubble with very homogeneous diameters and distinct shell thickness/strength (07-46)
Contrast agents for ultrasonic imaging, destruction of clots, ultrasound-induced permeability of blood vessels and other tissues, targeted drug delivery, or to enhance ultrasonic tissue ablation. More
Processes for Preparing Nanowire Scaffolds on Metallic Substrates and Uses of the Scaffolds (07-42)
Medical and dental uses of biocompatible nanofiber scaffolds More
Displaying 1..10 of 27 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Deals and alliances in cardiovascular and circulatory diseases
Jan 2006 - 1126 pages - $2,495
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
CardioVascular BioTherapeutics, Inc. – Product Pipeline Review – Q1 2011
May 2011 - 43 pages - $500
CardioVascular BioTherapeutics, Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 40 pages - $500
CV & Diabetes Market Forecast
Jan 2009 - $15,200
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Feb 2011 - 209 pages - $3,500
Osaka Medical Center for Cancer and Cardiovascular Diseases – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 36 pages - $500
Who's Developing What in Cardiovascular Devices?
Sep 2010 - 412 pages - $1,040
Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients
Nov 2010 - 7 pages - $500
Innovations in Cardiovascular Disease Management
May 2007 - 183 pages - $2,875
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us